Benchmark Trims Cross Country Healthcare (NASDAQ:CCRN) Target Price to $19.00

Cross Country Healthcare (NASDAQ:CCRN) had its target price reduced by Benchmark from $21.00 to $19.00 in a research report report published on Thursday, Benzinga reports. They currently have a buy rating on the business services provider’s stock.

Other equities analysts have also issued research reports about the stock. TheStreet lowered shares of Cross Country Healthcare from a b- rating to a c+ rating in a report on Friday, March 1st. Barrington Research reduced their target price on Cross Country Healthcare from $26.00 to $24.00 and set an outperform rating on the stock in a report on Tuesday, February 27th. Finally, Truist Financial dropped their price target on Cross Country Healthcare from $22.00 to $16.00 and set a hold rating for the company in a research note on Thursday, February 22nd. Six analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of Hold and a consensus target price of $21.33.

Cross Country Healthcare Stock Down 0.4 %

Shares of CCRN stock traded down $0.07 during mid-day trading on Thursday, hitting $16.67. 553,081 shares of the company’s stock were exchanged, compared to its average volume of 287,450. The stock has a market cap of $578.12 million, a price-to-earnings ratio of 12.82, a PEG ratio of 1.85 and a beta of 0.77. Cross Country Healthcare has a fifty-two week low of $15.65 and a fifty-two week high of $28.75. The stock has a 50-day simple moving average of $17.92 and a two-hundred day simple moving average of $20.03.

Cross Country Healthcare (NASDAQ:CCRN) last issued its quarterly earnings results on Wednesday, May 1st. The business services provider reported $0.19 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.17 by $0.02. Cross Country Healthcare had a return on equity of 11.69% and a net margin of 2.58%. The firm had revenue of $379.17 million for the quarter, compared to analyst estimates of $374.38 million. During the same period last year, the company earned $0.84 EPS. The firm’s quarterly revenue was down 39.1% on a year-over-year basis. As a group, analysts anticipate that Cross Country Healthcare will post 0.9 earnings per share for the current fiscal year.

Insider Transactions at Cross Country Healthcare

In related news, insider Karen Mote sold 6,216 shares of the firm’s stock in a transaction on Friday, March 15th. The shares were sold at an average price of $16.95, for a total transaction of $105,361.20. Following the completion of the sale, the insider now directly owns 35,101 shares of the company’s stock, valued at approximately $594,961.95. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Corporate insiders own 4.90% of the company’s stock.

Institutional Trading of Cross Country Healthcare

Several institutional investors have recently added to or reduced their stakes in CCRN. Allspring Global Investments Holdings LLC increased its holdings in Cross Country Healthcare by 212.9% in the first quarter. Allspring Global Investments Holdings LLC now owns 12,089 shares of the business services provider’s stock valued at $226,000 after buying an additional 8,225 shares during the last quarter. Assenagon Asset Management S.A. acquired a new stake in shares of Cross Country Healthcare during the 1st quarter valued at approximately $2,078,000. Paradiem LLC boosted its holdings in Cross Country Healthcare by 112.8% in the first quarter. Paradiem LLC now owns 136,294 shares of the business services provider’s stock worth $2,551,000 after purchasing an additional 72,244 shares during the period. Denali Advisors LLC increased its stake in Cross Country Healthcare by 3,885.5% during the first quarter. Denali Advisors LLC now owns 5,500 shares of the business services provider’s stock valued at $103,000 after purchasing an additional 5,362 shares during the last quarter. Finally, Wasatch Advisors LP increased its stake in Cross Country Healthcare by 74.3% during the fourth quarter. Wasatch Advisors LP now owns 2,193,604 shares of the business services provider’s stock valued at $49,663,000 after purchasing an additional 934,841 shares during the last quarter. 96.03% of the stock is owned by institutional investors and hedge funds.

Cross Country Healthcare Company Profile

Cross Country Healthcare, Inc provides talent management and other consultative services for healthcare clients in the United States. The company's Nurse and Allied Staffing segment provides traditional staffing, recruiting, and value-added total talent solutions, including temporary and permanent placement of travel and local nurse and, allied professionals; temporary placement of healthcare leaders within nursing, allied, physician, and human resources; vendor neutral and managed services programs; education healthcare services; in-home care services; and outsourcing services.